June 15, 2026 FDA Approves Teplizumab for Children With Stage 3 Type 1 Diabetes – Despite Delays & Controversy
April 25, 2026 FDA Accelerates Psychedelic Drug Review with Priority Review Vouchers for Compass, Usona and Transcend in Mental Health Push
February 13, 2026 FDA Rejects Disc Medicine’s Porphyria Drug Bitopertin in First Test of Makary Fast-Track Program
February 12, 2026 FDA Rejection of Moderna Flu Vaccine Fuels Fears of Vaccine Industry Paralysis Under Kennedy Administration
